Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 4
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M
Q3’25 Psychedelic Lobbying Update
Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher
The Psychedelic News Feed: October 20 – 26, 2025
Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed
Pα+ Psychedelic Bulletin #209: Aussie Insurer Covers Psilocybin for TRD; atai...
Dr. Cat Meyer – Sex, Love, Psychedelics
Breakthrough Data, Black Box Sessions: A Closer Look at MindMed’s Phase...
UK Royal College of Psychiatrists Weighs In: Promise in Psychedelics, But...
Dee Dee Goldpaugh – Embracing Pleasure
Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts
‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance
August 2025 Psychedelic Patent Update
Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos
Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56...
1
...
3
4
5
...
300
Page 4 of 300
